Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Wang, Joshua W.
Roden, Richard B. S.
Funding for this research was provided by:
National Cancer Institute (5P20CA192988-03, 5R01CA114425-10)
Text and Data Mining valid from 2016-02-25
Version of Record valid from 2016-02-25
23 December 2015
7 February 2016
25 February 2016